Previous studies have shown that CCR4+ T cells can be recruited to the GBM microenvironment (Ti-CCR4+ T cells) (12, 32), and our data further indicated that CD4+CCR4+ T cells were relatively specifically enriched in GBM and more abundant in the tumor microenvironment than those in the peripheral blood. The gene discussed is CCR4; the disease is glioblastoma.